YBGJ — Yubo International Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Yubo International Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 February 29th	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.001	0.028	0.018	0.006	0.007
Net Total Accounts Receivable
Net Total Receivables	—	0.56	0.345	0.366	0.442
Total Inventory
Prepaid Expenses
Total Current Assets	0.001	1.06	0.75	0.725	0.683
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	3.34	1.41	0.767	0.685
Net Intangible Assets
Other Long Term Assets
Total Assets	0.001	4.59	2.35	1.67	1.53
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.8	2.79	2.52	3.4	4.72
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	1.8	4.72	2.91	3.51	4.96
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-1.8	-0.131	-0.565	-1.84	-3.42
Total Liabilities & Shareholders' Equity	0.001	4.59	2.35	1.67	1.53
Total Common Shares Outstanding